Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

SP-04 and its metabolite: a novel therapeutic approach for Alzheimer's disease

Oct. 18, 2006

Targeting sEH as a novel strategy for inflammatory pain relief

Oct. 18, 2006

Novel choline analogue enhances cognition in monkeys

Oct. 18, 2006

Preclinical studies detail CNS-7056X characteristics

Oct. 18, 2006

AD-337 studied in fibromyalgia syndrome proof-of-principle study

Oct. 18, 2006

Tezampanel begins phase IIb for treatment of acute migraine

Oct. 18, 2006

End-of-phase II meeting for NRP-290

Oct. 18, 2006

Delay to gaboxadol NDA filing

Oct. 18, 2006

Wyeth presents the neuroprotective effects of novel Src kinase inhibitor in stroke

Oct. 17, 2006

Aricept approved for severe Alzheimer's disease

Oct. 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...